Brain Artificial Intelligence (AI)-Assisted Diagnosis Solution Market to Witness Significant Growth of USD $5.45 Billion with 25.6% CAGR by 2029

 Get 30% Off Market Intelligence Reports With Code ONLINE30 — Track Global Tariffs, Economic Shifts, and Sector Transformations

 

 What Are the Long-Term Growth Opportunities and Market Size Outlook for the Brain Artificial Intelligence (AI)-Assisted Diagnosis Solution Market?
 The brain artificial intelligence (AI)-assisted diagnosis solution market size has grown exponentially in recent years. It will grow from $1.74 billion in 2024 to $2.19 billion in 2025 at a compound annual growth rate (CAGR) of 25.9%. The growth in the historic period can be attributed to increasing prevalence of neurological disorders, rising healthcare awareness, growing burden of mental health conditions, surge in geriatric population, expansion of hospital infrastructure, and increasing demand for early disease detection.
 
 The brain artificial intelligence (AI)-assisted diagnosis solution market size is expected to see exponential growth in the next few years. It will grow to $5.46 billion in 2029 at a compound annual growth rate (CAGR) of 25.6%. The growth in the forecast period can be attributed to increasing government initiatives in healthcare digitization, rising adoption of preventive healthcare practices, growing number of specialized diagnostic centers, expansion of patient preference for non-invasive diagnosis, and surge in public-private healthcare collaborations. Major trends in the forecast period include advancements in neuroimaging, development of personalized diagnostic platforms, innovation in hybrid therapeutic and diagnostic solutions, investment in artificial intelligence research and development, integration of big data analytics in brain health, and integration of virtual reality-based cognitive assessments.
 
 Claim your free report sample now:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=28153&type=smp
 
 What Are the Key Drivers of the Brain Artificial Intelligence (AI)-Assisted Diagnosis Solution Market?
 The increasing prevalence of neurological disorders is expected to propel the growth of the brain artificial intelligence (AI)-assisted diagnosis solution market going forward. Neurological disorders are medical conditions that affect the brain, spinal cord, and nerves, leading to a range of symptoms, including cognitive, motor, and sensory impairments. The increasing prevalence of neurological disorders is linked to the aging global population, as aging gradually impairs neuronal function, reduces brain plasticity, and elevates oxidative stress, contributing to the development and progression of these conditions. Brain artificial intelligence (AI)-assisted diagnosis solutions aid in neurological disorders diagnosis by providing rapid, accurate, and objective analysis of brain imaging or electrical activity. They enhance clinical decision-making, support early detection of conditions such as stroke, concussion, and Alzheimer’s, and enable personalized treatment planning. For instance, in July 2024, according to the National Health Service, a UK-based government agency, there were 487,432 patients diagnosed with dementia (a progressive brain disorder affecting memory, thinking, and daily activities) by June 30, 2024, an increase of 3,155 cases compared to May 31, 2024. Therefore, the increasing prevalence of neurological disorders is driving the growth of the brain artificial intelligence (AI)-assisted diagnosis solutions market.
 
 How Is the Brain Artificial Intelligence (AI)-Assisted Diagnosis Solution Market Divided by Type and Application?
 The brain artificial intelligence (AI)-assisted diagnosis solution market covered in this report is segmented as
 
 1) By Component: Hardware, Services, Software
 2) By Technology: Computer Vision, Deep Learning, Machine Learning, Natural Language Processing
 3) By Deployment: Cloud, On-Premise
 4) By Application: Disease Detection, Patient Monitoring, Radiology Analysis, Surgical Robotics Assistance
 5) By End User: Clinics, Diagnostic Centers, Hospitals, Research Institutes
 
 Subsegments:
 1) By Hardware: Imaging Systems, artificial intelligence (AI)-Optimized Processors, Data Storage Systems, Networking And Communication Devices, Workstations And Diagnostic Terminals
 2) By Services: Consulting And Integration Services, Training And Education Services, Deployment And Implementation Services, Support And Maintenance Services, Managed AI Services
 3) By Software: Diagnostic Imaging Analysis Software, Machine Learning And Deep Learning Algorithms, Natural Language Processing (NLP) Tools, Clinical Decision Support Systems (CDSS), Data Management And Analytics Platforms, Cloud-Based artificial intelligence (AI) Platforms
 
 What Are the Key Trends Shaping the Brain Artificial Intelligence (AI)-Assisted Diagnosis Solution Market?
 Major companies operating in the brain artificial intelligence (AI)-assisted diagnosis solution market are focusing on developing technologically advanced solutions, such as deep learning platforms, to enhance diagnostic accuracy, real-time analysis, and clinical decision-making. Deep learning platforms are intelligent digital systems that leverage advanced neural networks and data analytics to analyze brain electrical activity or imaging data, detect subtle abnormalities, and provide actionable insights for clinicians. For instance, in June 2025, BrainScope Company Inc., a US-based neurotechnology company, launched its next-generation deep learning platform featuring a Large Neural Model (LNM). This platform applies breakthroughs similar to large language models (LLMs) to electroencephalogram (EEG) data, enabling automated analysis without specialized quantitative EEG (qEEG) interpretation. It supports diverse brain health conditions, including concussion, stroke, and early Alzheimer’s detection, by delivering rapid, objective, and clinically actionable insights. The platform also facilitates the development of refined biomarkers for precision-driven clinical trial recruitment, early diagnosis, and personalized treatment.
 
 What Are the Top Companies to Watch in the Brain Artificial Intelligence (AI)-Assisted Diagnosis Solution Market?
 Major companies operating in the brain artificial intelligence (ai)-assisted diagnosis solution market are Viz.ai Inc., Aidoc Medical Ltd., RapidAI Inc., Qure.ai Technologies Pvt. Ltd., Ceribell Inc., Infervision Inc., Quibim S.L., Brainomix Ltd., Hyperfine Inc., QMENTA Inc., BrainScope Company Inc., BioMind Inc., Cortechs.ai Inc., Heuron Inc., Zeto Inc., icometrix NV, Cercare Medical AB, VUNO Inc., NeuraSignal Inc., Aikenist Inc., Avicenna.AI Inc., BrainKey Technologies Inc., and Deepwise AI Co. Ltd.
 
 Get the full brain artificial intelligence (ai)-assisted diagnosis solution market report here:
 https://www.thebusinessresearchcompany.com/report/brain-artificial-intelligence-ai-assisted-diagnosis-solution-global-market-report
 
 How Does Brain Artificial Intelligence (AI)-Assisted Diagnosis Solution Market Growth Vary Across Major Regions?
 North America was the largest region in the brain artificial intelligence (AI)-assisted diagnosis solution market in 2024. The regions covered in brain artificial intelligence (AI)-assisted diagnosis solution report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company